Diverse inhibition of plasminogen activator inhibitor type 1 by theaflavins of black tea

International Journal of Molecular Medicine

Volumn 27, Issue 4, 2011, Pages 525-529

  Jankun, Jerzy ^a,b,c   Skotnicka, Magdalena ^a,b   Łysiak Szydłowska, Wiesława ^b   Al Senaidy, Abdulrahman ^c   Skrzypczak Jankun, Ewa ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Black tea; Plasminogen activator inhibitor; Polyphenols; Theaflavins

Indexed keywords

ANTIFIBRINOLYTIC AGENT; BLACK TEA EXTRACT; NUTRACEUTICAL; PLASMINOGEN ACTIVATOR INHIBITOR 1; THEAFLAVIN; THEAFLAVIN 3,3' GALLATE; THEAFLAVINE 3 GALLATE; THEAFLAVINE 3' GALLATE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOT LYSIS; BLOOD CLOTTING; BLOOD SAMPLING; CONTROLLED STUDY; DRUG POTENCY; DRUG PURIFICATION; DRUG STRUCTURE; HUMAN; PRIORITY JOURNAL; TEA; THROMBOELASTOGRAPHY; TURBIDITY;

ANTIOXIDANTS; BIFLAVONOIDS; CATECHIN; FIBRINOLYSIS; HUMANS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN BINDING; RECOMBINANT PROTEINS; TEA; THROMBOSIS;

EID: 79952221147     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.615     Document Type: Article

References (29)

1. Aggarwal BB and Shishodia S: Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71: 1397-1421, 2006.
2. Frank B and Gupta S: A review of antioxidants and Alzheimer's disease. Ann Clin Psychiatry 17: 269-286, 2005
3. Jankun J, Aleem AM, Malgorzewicz S, et al: Synthetic curcuminoids modulate the arachidonic acid metabolism of human platelet 12-lipoxygenase and reduce sprout formation of human endothelial cells. Mol Cancer Ther 5: 1371-1382, 2006. (Pubitemid 43881331)
4. Agrawal DK and Mishra PK: Curcumin and its analogues: potential anticancer agents. Med Res Rev 30: 818-860, 2010.
5. Hanai H and Sugimoto K: Curcumin has bright prospects for the treatment of inflammatory bowel disease. Curr Pharm Des 15: 2087-2094, 2009.
6. Jurenka JS: Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern Med Rev 14: 141-153, 2009.
7. Brown NJ: Therapeutic potential of plasminogen activator inhibitor-1 inhibitors. Ther Adv Cardiovasc Dis 4: 315-324, 2010.
8. Van Nostrand WE and Porter M: Plasmin cleavage of the amyloid beta-protein: alteration of secondary structure and stimulation of tissue plasminogen activator activity. Biochemistry 38: 11570-11576, 1999.
9. Wood PA: Connecting the dots: obesity, fatty acids and cancer. Lab Invest 89: 1192-1194, 2009.
10. Chorostowska-Wynimko J, Świercz R, Skrzypczak-Jankun E, Wojtowicz A, Selman SH and Jankun J: A novel form of the plasminogen activator inhibitor created by cysteine mutations extends its half-life: relevance to cancer and angiogenesis. Mol Cancer Ther 2: 19-28, 2003.
11. Skrzypczak-Jankun E and Jankun J: Theaflavin digallate inactivates plasminogen activator inhibitor: could tea help in Alzheimer's disease and obesity? Int J Mol Med 26: 45-50, 2010.
12. Bastianetto S, Yao ZX, Papadopoulos V and Quirion R: Neuroprotective effects of green and black teas and their catechin gallate esters against beta-amyloid-induced toxicity. Eur J Neurosci 23: 55-64, 2006.
13. Cesari M, Pahor M and Incalzi RA: Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions. Cardiovasc Ther 28: 72-91, 2010.
14. Chen N, Bezzina R, Hinch E, et al: Green tea, black tea, and epigallocatechin modify body composition, improve glucose tolerance, and differentially alter metabolic gene expression in rats fed a high-fat diet. Nutr Res 29: 784-793, 2009.
15. Higgins PJ: The TGF-beta1/upstream stimulatory factor-regulated PAI-1 gene: potential involvement and a therapeutic target in Alzheimer's disease. J Biomed Biotechnol 2006: 15792, 2006.
16. Jankun J, Aleem AM, Selman SH, Basrur V and Skrzypczak-Jankun E: VLHL plasminogen activator inhibitor spontaneously reactivates from the latent to active form. Int J Mol Med 23: 57-63, 2009.
17. Evans PA, Hawkins K, Lawrence M, Barrow MS, Williams PR and Williams RL: Studies of whole blood coagulation by oscillatory shear, thromboelastography and free oscillation rheometry. Clin Hemorheol Microcirc 38: 267-277, 2008. (Pubitemid 351521578)
18. Carr ME Jr, Krishnamurti C and Alving BM: Effect of plasminogen activator inhibitor-1 on tissue-type plasminogen activator-induced fibrinolysis. Thromb Haemost 67: 106-110, 1992.
19. Jankun J, Aleem AM, Selman SH, et al: Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis. Int J Mol Med 20: 683-687, 2007.
20. TEG 5000 User's Manual Version 4.2 Software. Haemoscope Corporation, 2006.
21. Kolev K, Varju I, Szabo L, Machovich R, Silva M and Longstaff C: Hampered dissolution of fibrin formed under mechanical stress. J Thromb Haemost 8: 44, 2010.
22. Boon H and Wong J: Botanical medicine and cancer: a review of the safety and efficacy. Expert Opin Pharmacother 5: 2485-2501, 2004. (Pubitemid 39646512)
23. Vorster H, Jerling J, Oosthuizen W, et al: Tea drinking and haemostasis: a randomized, placebo-controlled, crossover study in free-living subjects. Haemostasis 26: 58-64, 1996. (Pubitemid 26048902)
24. Świercz R, Skrzypczak-Jankun E, Merrell MM, Selman SH and Jankun J: Angiostatic activity of synthetic inhibitors of urokinase type plasminogen activator. Oncol Rep 6: 523-526, 1999.
25. Loktionov A, Bingham SA, Vorster H, Jerling JC, Runswick SA and Cummings JH: Apolipoprotein E genotype modulates the effect of black tea drinking on blood lipids and blood coagulation factors: a pilot study. Br J Nutr 79: 133-139, 1998. (Pubitemid 28081863)
26. Hill JM, Bhattacharjee PS and Neumann DM: Apolipoprotein E alleles can contribute to the pathogenesis of numerous clinical conditions including HSV-1 corneal disease. Exp Eye Res 84: 801-811, 2007. (Pubitemid 46590122)
27. Crozier A, Jaganath IB and Clifford MN: Dietary phenolics: chemistry, bioavailability and effects on health. Nat Prod Rep 26: 1001-1043, 2009.
28. Rechner AR, Wagner E, Van Buren L, Van De Put F, Wiseman S and Rice-Evans CA: Black tea represents a major source of dietary phenolics among regular tea drinkers. Free Radic Res 36: 1127-1135, 2002.
29. Kuroda Y and Hara Y: Antimutagenic and anticarcinogenic activity of tea polyphenols. Mutat Res 436: 69-97, 1999. (Pubitemid 29044047)